Package 63323-117-10

{"route": ["INTRAVENOUS"], "spl_id": "c346206d-110e-4358-800d-9245e59a0491", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0363323117016", "0363323117009"], "unii": ["U3P01618RT"], "rxcui": ["239177", "1791701", "1791736"], "spl_set_id": ["c45f5286-a52b-43e5-8a6f-d0312e7da0c8"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 TRAY (63323-117-10)  / 10 mL in 1 VIAL, SINGLE-DOSE (63323-117-00)", "package_ndc": "63323-117-10", "marketing_start_date": "20170102"}, {"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 TRAY (63323-117-20)  / 20 mL in 1 VIAL, SINGLE-DOSE (63323-117-01)", "package_ndc": "63323-117-20", "marketing_start_date": "20170102"}], "brand_name": "Fluorouracil", "product_id": "63323-117_c346206d-110e-4358-800d-9245e59a0491", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "63323-117", "generic_name": "FLUOROURACIL", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluorouracil", "active_ingredients": [{"name": "FLUOROURACIL", "strength": "50 mg/mL"}], "application_number": "ANDA040279", "marketing_category": "ANDA", "marketing_start_date": "20170102", "listing_expiration_date": "20261231"}